New User:

-or-
Username:
Password:
Forgot your password?

Stock Market & Financial Investment News

News Breaks
October 31, 2012
11:54 EDTNUVANuVasive poised to take share after disc system approval, says Barrington
After NuVasive's PCM cervical disc system was approved by the FDA, Barrington thinks the device leaves the company poised to take share. The firm maintains a $25 target and Outperform rating on the stock.
News For NUVA From The Last 14 Days
Sign up for a free trial to see the rest of the stories you've been missing.
October 30, 2014
16:34 EDTNUVANuVasive raises FY14 EPS view to $1.12 from $1.11, consensus $1.12
Subscribe for More Information
16:32 EDTNUVANuVasive reports Q3 EPS 19c, consensus 25c
Reports Q3 revenue $189.9M, consensus $179.32M.

Sign up for a free trial to see the rest of the stories you've been missing.

I agree to the theflyonthewall.com disclaimer & terms of use